Wells Fargo & Company Morpho Sys Ag Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Morpho Sys Ag stock. As of the latest transaction made, Wells Fargo & Company holds 2,088 shares of MOR stock, worth $37,792. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,088

Previous 2,749 24.05%

Holding current value

$37,792

Previous $27,000 37.04%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$8.6 - $18.18 $5,684 - $12,016	-661 Reduced 24.05%	2,088 $37,000
Q4 2023 Feb 09, 2024	SELL	$4.55 - $9.9 $234,320 - $509,840	-51,499 Reduced 94.93%	2,749 $27,000
Q3 2023 Nov 13, 2023	BUY	$6.72 - $8.6 $39,755 - $50,877	5,916 Added 12.24%	54,248 $364,000
Q2 2023 Aug 15, 2023	BUY	$3.95 - $7.74 $190,911 - $374,089	48,332 New	48,332 $361,000
Q4 2022 Feb 13, 2023	SELL	$3.21 - $5.74 $1,412 - $2,525	-440 Reduced 77.74%	126 $0

Q3 2022 Nov 14, 2022	SELL	$4.14 - $22.13 $1,159 - $6,196	-280 Reduced 33.1%	566 $3,000
Q2 2022 Aug 12, 2022	BUY	$4.51 - $7.39 $1,262 - $2,069	280 Added 49.47%	846 $4,000
Q1 2022 May 16, 2022	SELL	$5.87 - $9.73 $14,463 - $23,974	-2,464 Reduced 81.32%	566 $4,000
Q4 2021 Feb 14, 2022	BUY	$9.08 - $12.45 $8,217 - $11,267	905 Added 42.59%	3,030 $28,000
Q3 2021 Nov 15, 2021	SELL	$11.76 - $19.51 $110,144 - $182,730	-9,366 Reduced 81.51%	2,125 $25,000
Q2 2021 Aug 16, 2021	BUY	$18.95 - $23.95 $190,978 - $241,368	10,078 Added 713.23%	11,491 $221,000
Q1 2021 May 13, 2021	SELL	$21.56 - $30.66 $14,897 - $21,186	-691 Reduced 32.84%	1,413 $31,000
Q4 2020 Feb 09, 2021	BUY	$24.81 - $30.33 $124 - $151	5 Added 0.24%	2,104 $60,000
Q3 2020 Nov 05, 2020	BUY	$30.28 - $35.72 $968 - $1,143	32 Added 1.55%	2,099 $66,000
Q2 2020 Aug 13, 2020	BUY	$24.08 - $33.35 $13,581 - $18,809	564 Added 37.52%	2,067 $65,000
Q1 2020 May 14, 2020	BUY	$18.86 - $37.36 $28,346 - $56,152	1,503 New	1,503 $37,000

Others Institutions Holding MOR

# of Institutions

Shares Held

11.3M

Call Options Held

320K

Put Options Held

1.1M

View Full List

About MorphoSys AG

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Market Cap $2.47B
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

More about MOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Morpho Sys Ag Transaction History